Drawing for ADVANCE THE CELL & GENE THERAPY COLLECTIVE

USPTO serial 90226712

ADVANCE THE CELL & GENE THERAPY COLLECTIVE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BRACEY, KAREN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADVANCE THE CELL & GENE THERAPY COLLECTIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donna H. Hartman

Donna H. Hartman OLENDERFELDMAN LLP422 MORRIS AVESUMMIT, NJ 07901UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business management consulting services to the pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business and management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business services provided to the healthcare industry, namely, the creation, collection, analysis, and reporting of health care data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutritionACTIVE—
041Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industryACTIVE—
042Scientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and food and nutritionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 1, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 1, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 29, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 27, 2021EX1GSOU EXTENSION 1 GRANTED—
Oct 27, 2021EXT1SOU EXTENSION 1 FILED—
Oct 27, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 29, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 4, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 4, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 14, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 29, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2021DOCKASSIGNED TO EXAMINER—
Nov 15, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance